Pro-angiogenic induction of myeloid cells for therapeutic angiogenesis can induce mitogen-activated protein kinase p38-dependent foam cell formation

Cytotherapy

Volumn 13, Issue 4, 2011, Pages 503-512

  Rohde, Eva ^a,b,g   Schallmoser, Katharina ^a,b   Reinisch, Andreas ^a,c   Hofmann, Nicole A ^a,c   Pfeifer, Thomas ^d   Fröhlich, Eleonore ^e   Rechberger, Gerald ^f   Lanzer, Gerhard ^b   Kratky, Dagmar ^d   Strunk, Dirk ^a,c,e  

^a Stem Cell Research Unit   (Austria)

^b Department of Blood Group Serology and Transfusion Medicine ^*  (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d Center for Molecular Medicine   (Austria)

^e MEDICAL UNIVERSITY OF GRAZ   (Austria)

^f UNIVERSITY OF GRAZ   (Austria)

^g Universit A Tsklinik fur Blutgruppenserologie und Transfusionsmedizin   (Austria)

Author keywords

atherogenesis; foam cell formation; mitogen activated protein kinase inhibition; stem cell therapy; therapeutic angiogenesis

Indexed keywords

CHOLESTEROL; FAT DROPLET; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; STAT1 PROTEIN; STAT3 PROTEIN;

ANGIOGENESIS; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL STIMULATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; FLOW CYTOMETRY; FOAM CELL; HEMATOPOIESIS; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MESENCHYME CELL; MONOCYTE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 79952676769     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653249.2010.536214     Document Type: Article

References (43)

1. Epstein SE, Stabile E, Kinnaird T, Lee CW, Clavijo L, Burnett MS. Janus phenomenon: the interrelated tradeoffs inherent in therapies designed to enhance collateral formation and those designed to inhibit atherogenesis. Circulation. 2004;109: 2826-31. (Pubitemid 38786445)
2. Weber C, Zernecke A, Libby P. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat Rev Immunol. 2008;8:802-15.
3. Werner N, Junk S, Laufs U, Link A, Walenta K, Bohm M, et al. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res. 2003;93:e17-24.
4. Doyle B, Sorajja P, Hynes B, Kumar AH, Araoz PA, Stalboerger PG, et al. Progenitor cell therapy in a porcine acute myocardial infarction model induces cardiac hypertrophy, mediated by paracrine secretion of cardiotrophic factors including TGFbeta1. Stem Cells Dev. 2008;17:941-51.
5. Rohde E, Malischnik C, Thaler D, Maierhofer T, Linkesch W, Lanzer G, et al. Blood monocytes mimic endothelial progenitor cells. Stem Cells. 2006;24:357-67. (Pubitemid 44464805)
6. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H, et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med. 2006;355:1210-21. (Pubitemid 44427445)
7. Assmus B, Honold J, Schachinger V, Britten MB, Fischer-Rasokat U, Lehmann R, et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med. 2006;355:1222-32. (Pubitemid 44427446)
8. Silvestre JS, Gojova A, Brun V, Potteaux S, Esposito B, Duriez M, et al. Transplantation of bone marrow-derived mononu-clear cells in ischemic apolipoprotein E-knockout mice accelerates atherosclerosis without altering plaque composition. Circulation. 2003;108:2839-42. (Pubitemid 37517809)
9. George J, Afek A, Abashidze A, Shmilovich H, Deutsch V, Kopolovich J, et al. Transfer of endothelial progenitor and bone marrow cells infl uences atherosclerotic plaque size and composition in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol. 2005;25:2636-41. (Pubitemid 43732290)
10. Kang HJ, Kim HS, Zhang SY, Park KW, Cho HJ, Koo BK, et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet. 2004;363:751-6.
11. Mansour S, Vanderheyden M, De Bruyne B, Vandekerckhove B, Delrue L, Van Haute I, et al. Intracoronary delivery of hematopoietic bone marrow stem cells and luminal loss of the infarct-related artery in patients with recent myocardial infarction. J Am Coll Cardiol. 2006;47:1727-30.
12. Bartunek J, Vanderheyden M, Vandekerckhove B, Mansour S, De Bruyne B, De Bondt P, et al. Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety. Circulation. 2005;112:I178-83. (Pubitemid 41266671)
13. Anami Y, Kobori S, Sakai M, Kasho M, Nishikawa T, Yano T, et al. Human beta-migrating very low density lipoprotein induces foam cell formation in human mesangial cells. Atherosclerosis. 1997;135:225-34. (Pubitemid 28015189)
14. Haust MD. Myogenic foam cells in explants of fatty dots and streaks from rabbit aorta. Morphological studies. Atherosclerosis. 1977;26:441-64. (Pubitemid 8076488)
15. Grande J, Davis HR, Bates S, Mathews MB, Glagov S. Effect of an elastin growth substrate on cholesteryl ester synthesis and foam cell formation by cultured aortic smooth muscle cells. Atherosclerosis. 1987;68:87-93. (Pubitemid 17151109)
16. Strunk D, Rohde E, Lanzer G, Linkesch W. Phenotypic characterization and preclinical production of human lineage-negative cells for regenerative stem cell therapy. Transfusion. 2005;45:315-26. (Pubitemid 40389425)
17. Bartmann C, Rohde E, Schallmoser K, Purstner P, Lanzer G, Linkesch W, et al. Two steps to functional mesenchymal stromal cells for clinical application. Transfusion. 2007;47:1426-35. (Pubitemid 47101059)
18. Schallmoser K, Rohde E, Reinisch A, Bartmann C, Thaler D, Drexler C, et al. Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum. Tissue Eng Part C Methods. 2008;14: 185-96.
19. Reinisch A, Hofmann NA, Obenauf AC, Kashofer K, Rohde E, Schallmoser K, et al. Humanized large-scale expanded endothelial colony-forming cells function in vitro and in vivo. Blood. 2009;113:6716-25.
20. Bieback K, Hecker A, Kocaomer A, Lannert H, Schallmoser K, Strunk D, et al. Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells. 2009;27:2331-41.
21. Reinisch A, Strunk D. Isolation and animal serum free expansion of human umbilical cord derived mesenchymal stromal cells (MSCs) and endothelial colony forming progenitor cells (ECFCs). J Vis Exp. 2009;(32) doi: 103791/1525.
22. Schallmoser K, Strunk D. Preparation of pooled human platelet lysate (pHPL) as an efficient supplement for animal serum-free human stem cell cultures. J Vis Exp. 2009;(32) doi: 103791/1523.
23. Schachinger V, Assmus B, Britten MB, Honold J, Lehmann R, Teupe C, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: finalone-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol. 2004;44:1690-9. (Pubitemid 39369805)
24. Erbs S, Linke A, Adams V, Lenk K, Thiele H, Diederich KW, et al. Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: first randomized and placebocontrolled study. Circ Res. 2005;97: 756-62. (Pubitemid 41447125)
25. Basu SK, Goldstein JL, Anderson GW, Brown MS. Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. Proc Natl Acad Sci USA. 1976;73:3178-82.
26. Reinisch A, Bartmann C, Rohde E, Schallmoser K, Bjelic-Radisic V, Lanzer G, et al. Humanized system to propagate cord blood-derived multipotent mesenchymal stromal cells for clinical application. Regen Med. 2007;2:371-82. (Pubitemid 47304957)
27. Rohde E, Bartmann C, Schallmoser K, Reinisch A, Lanzer G, Linkesch W, et al. Immune cells mimic the morphology of endothelial progenitor colonies in vitro. Stem Cells. 2007;25: 1746-52. (Pubitemid 47121853)
28. Farese RV, Walther TC. Lipid droplets finally get a little R-E-S-P-E-C-T. Cell. 2009;139:855-60.
29. Zhao M, Liu Y, Wang X, New L, Han J, Brunk UT. Activation of the p38 MAP kinase pathway is required for foam cell formation from macrophages exposed to oxidized LDL. APMIS. 2002;110:458-68. (Pubitemid 34856488)
30. Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature. 2001;410:37-40. (Pubitemid 32225829)
31. Assmus B, Schachinger V, Teupe C, Britten M, Lehmann R, Dobert N, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOP-CARE-AMI). Circulation. 2002;106:3009-17. (Pubitemid 35440281)
32. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 2001;89:E1-7.
33. Buja LM, Kovanen PT, Bilheimer DW. Cellular pathology of homozygous familial hypercholesterolemia. Am J Pathol. 1979; 97:327-57. (Pubitemid 10214586)
34. Brown MS, Goldstein JL, Krieger M, Ho YK, Anderson RG. Reversible accumulation of cholesteryl esters in macrophages incubated with acetylated lipoproteins. J Cell Biol. 1979;82: 597-613. (Pubitemid 10222832)
35. Rudolph V, Andrie RP, Rudolph TK, Friedrichs K, Klinke A, Hirsch-Hoffmann B, et al. Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation. Nat Med. 2010;16:470-4.
36. Wang WY, Li J, Yang D, Xu W, Zha RP, Wang YP. OxLDL stimulates lipoprotein-associated phospholipase A2 expression in THP-1 monocytes via PI3K and p38 MAPK pathways. Cardiovasc Res. 2010;85:845-52.
37. Haust MD. The nature of bi- and trinuclear cells in atherosclerotic lesions in man Ultrastructural studies of aortic fatty dots and streaks. Atherosclerosis. 1980;36:365-77. (Pubitemid 10064765)
38. Timmermans F, Plum J, Yoder MC, Ingram DA, Vandekerck-hove B, Case J. Endothelial progenitor cells: identity defined? J Cell Mol Med. 2009;13:87-102.
39. Meleromartin J, De Obaldia ME, Allen P, Dudley AC, Klagsbrun M, Bischoff J. Host myeloid cells are necessary for creating bio-engineered human vascular networks in vivo. Tissue Eng Part A. 2010:16(8):2457-66.
40. Apostolakis S, Lip GY, Shantsila E. Monocytes in heart failure: relationship to a deteriorating immune overreaction or a desperate attempt for tissue repair? Cardiovasc Res. 2010;85: 649-60.
41. Huikuri HV, Kervinen K, Niemela M, Ylitalo K, Saily M, Koistinen P, et al. Effects of intracoronary injection of mono-nuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction. Eur Heart J. 2008;29: 2723-32.
42. Jiang S, Haider H, Idris NM, Salim A, Ashraf M. Supportive interaction between cell survival signaling and angiocompe-tent factors enhances donor cell survival and promotes angi-omyogenesis for cardiac repair. Circ Res. 2006;99:776-84. (Pubitemid 44498311)
43. Kobayashi T, Hamano K, Li TS, Katoh T, Kobayashi S, Mat-suzaki M, et al. Enhancement of angiogenesis by the implantation of self bone marrow cells in a rat ischemic heart model. J Surg Res. 2000;89:189-95. (Pubitemid 30196524)